Avrobio Inc. (AVRO) PT Raised to $36 at Wedbush

February 11, 2020 11:52 AM EST
Get Alerts AVRO Hot Sheet
Price: $7.33 -3.17%

Rating Summary:
    12 Buy, 3 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 18 | Down: 11 | New: 19
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Wedbush analyst David Nierengarten raised the price target on Avrobio Inc. (NASDAQ: AVRO) to $36.00 (from $32.00) while maintaining a Outperform rating after the company updated their gene therapy program in Fabry disease (AVR-RD-01) and gave a first look at their program in cystinosis (AVR-RD-04).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change